Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lavic
NCT05206279Completed
- Sponsor
- Insel Gruppe
- Start
- Jun 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of indocyanine green in deep infiltrating endometriosis (DIE), sponsored by Insel Gruppe. Primary endpoint: Feasibility of visualization of the ureters by means of ICG / near-infrared-imaging technique. Started Jun 2023; status: completed.
02
Drugs
indocyanine green
03
Conditions
deep infiltrating endometriosis (DIE)
Beyond the preview
Go deeper on NCT05206279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05206279.